Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma
Hang Quach, Simon Benson, Helen Haysom, Anne-Marie Wilkes, Nicole Zacher, Merrole Cole-Sinclair, Henry Miles Prince, Peter Mollee, Andrew Spencer, Phoebe Joy Ho, Simon J Harrison, Cindy Lee, Bradley Augustson, James Daly
Internal Medicine Journal | WILEY | Published : 2018
Janssen-Cilag provided funding for the authorship group to meet and discuss the guidelines. Janssen-Cilag reviewed the guidelines for scientific accuracy, but the final decision to publish was solely the authors.